Gwynfor Owen Humphreys
No más puestos en curso
Historial de carrera de Gwynfor Owen Humphreys
Antiguos cargos conocidos de Gwynfor Owen Humphreys.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| AVACTA GROUP PLC | Director/Miembro de la Junta | 13/07/2006 | 23/01/2015 |
| Presidente | 24/12/2010 | 24/01/2014 | |
| GUNSYND PLC | Director/Miembro de la Junta | 01/10/2004 | 15/09/2014 |
| Director Ejecutivo | 03/05/2012 | 15/09/2014 | |
Nektar Therapeutics UK Ltd.
 Nektar Therapeutics UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Nektar Therapeutics, Nektar Therapeutics UK Ltd. develops and manages the exploitation of patented technology for controlled particle formation. The company is based in Bradford, UK. Nektar Therapeutics was acquired by Nektar Therapeutics on January 09, 2001 for $140.98 million. The British company was founded by Mazen Hanna, Gwynfor Owen Humphreys. | Fundador | 01/12/1995 | 01/01/2001 |
| Presidente | 01/12/1995 | 01/01/2001 | |
SolAeroMed, Inc.
 SolAeroMed, Inc. Pharmaceuticals: MajorHealth Technology SolAeroMed, Inc. develops biophysical respiratory drugs and delivery devices for asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). The company was founded by John Butt and Green Francis in 1995 and is headquartered in Calgary, Canada. | Director/Miembro de la Junta | - | - |
Estadísticas
Internacional
| Reino Unido | 4 |
| Canadá | 2 |
Operativa
| Director/Board Member | 3 |
| Chairman | 1 |
| Chief Executive Officer | 1 |
Sectorial
| Health Technology | 4 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| AVACTA GROUP PLC | Commercial Services |
| GUNSYND PLC | Health Technology |
| Empresas privadas | 2 |
|---|---|
Nektar Therapeutics UK Ltd.
Nektar Therapeutics UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Nektar Therapeutics, Nektar Therapeutics UK Ltd. develops and manages the exploitation of patented technology for controlled particle formation. The company is based in Bradford, UK. Nektar Therapeutics was acquired by Nektar Therapeutics on January 09, 2001 for $140.98 million. The British company was founded by Mazen Hanna, Gwynfor Owen Humphreys. | Health Technology |
SolAeroMed, Inc.
SolAeroMed, Inc. Pharmaceuticals: MajorHealth Technology SolAeroMed, Inc. develops biophysical respiratory drugs and delivery devices for asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). The company was founded by John Butt and Green Francis in 1995 and is headquartered in Calgary, Canada. | Health Technology |
